Who invested in RECEPTOR.AI

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Follow RECEPTOR.AI and see its new rounds in your feed. Start following

Funding summaryUpdated 15 Nov 2026

$11Mraised across 1 round since 2024, from 1 source

Latest round: Venture, $11MNov 2024
Investors: 0

See who backed them

The rounds

Nov 2024
Venture$11M
No investor was named in the report.
Source recorded

Founders and team

From RECEPTOR.AI's own website: 17 on the team.

Dr. Askar KuchumovHead of Business Development
Dr. Daniele AndreottiHead of Medicinal Chemistry
Dr. Martin IndarteHead of Computational Chemistry
Dr. Yaroslav BilokinHead of Chemistry
Daniil TodoryshynProduct Manager
Daryna KyrylovaMarketing Manager
Drug DiscoveryPlatform Developer
Hlib KholodulkinBusiness Administration Manager
Illia SavchenkoR&D Technical Lead
Roman HavryliukProject Manager
Sasha KorogodskiDrug Discovery Project Manager
Tetiana SkakunMarketing Manager
Tigran TsaturyanDrug Discovery Project Manager
Vladyslav HusakPlatform Manager
Dr. Alan NafievTeam
Dr. Semen YesylevskyyTeam
Dr. Sergii StarosylaTeam

AdvisersDr. Rajiah Aldrin DennyDr. Andrew GolubDr. Margot ErnstDr. Tomi K. SawyerProf. Christophe RamseyerProf. Kevin BurgessProf. Mikhail BogdanovProf. Scott Lokey